Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Delivery Systems | 6 | 2021 | 2221 | 1.270 |
Why?
|
Nanoparticles | 8 | 2021 | 1943 | 1.240 |
Why?
|
Intracranial Aneurysm | 3 | 2024 | 1276 | 1.150 |
Why?
|
von Willebrand Factor | 2 | 2020 | 673 | 1.050 |
Why?
|
Heart Valve Prosthesis | 2 | 2024 | 1495 | 1.010 |
Why?
|
Models, Cardiovascular | 6 | 2024 | 977 | 0.970 |
Why?
|
Thrombosis | 6 | 2024 | 3051 | 0.950 |
Why?
|
Platelet Adhesiveness | 3 | 2020 | 154 | 0.860 |
Why?
|
Platelet Membrane Glycoproteins | 2 | 2021 | 285 | 0.850 |
Why?
|
Thrombin | 1 | 2024 | 593 | 0.760 |
Why?
|
Fibrin | 1 | 2024 | 505 | 0.760 |
Why?
|
Carotid Artery Injuries | 1 | 2020 | 96 | 0.690 |
Why?
|
Blood Platelets | 7 | 2021 | 2519 | 0.660 |
Why?
|
Arteries | 2 | 2021 | 1126 | 0.650 |
Why?
|
Carotid Arteries | 2 | 2020 | 951 | 0.630 |
Why?
|
Fibrinolytic Agents | 4 | 2021 | 2167 | 0.570 |
Why?
|
Microfluidics | 1 | 2022 | 652 | 0.550 |
Why?
|
Hemodynamics | 7 | 2022 | 4173 | 0.550 |
Why?
|
Endothelial Cells | 4 | 2022 | 3539 | 0.470 |
Why?
|
Arterial Occlusive Diseases | 2 | 2015 | 752 | 0.470 |
Why?
|
Atherosclerosis | 2 | 2020 | 3518 | 0.450 |
Why?
|
Coronary Stenosis | 1 | 2019 | 820 | 0.430 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 1098 | 0.430 |
Why?
|
Nanomedicine | 1 | 2015 | 288 | 0.420 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2012 | 90 | 0.400 |
Why?
|
Stress, Mechanical | 4 | 2021 | 1666 | 0.330 |
Why?
|
Nanotechnology | 1 | 2015 | 709 | 0.320 |
Why?
|
Platelet Aggregation | 3 | 2021 | 805 | 0.320 |
Why?
|
Shear Strength | 2 | 2021 | 161 | 0.300 |
Why?
|
Pulsatile Flow | 2 | 2019 | 321 | 0.300 |
Why?
|
Tissue Engineering | 3 | 2022 | 1870 | 0.270 |
Why?
|
Tissue Plasminogen Activator | 1 | 2012 | 1190 | 0.270 |
Why?
|
Biomimetic Materials | 2 | 2021 | 173 | 0.260 |
Why?
|
Birds | 1 | 2024 | 168 | 0.230 |
Why?
|
Hemostasis | 3 | 2021 | 468 | 0.230 |
Why?
|
Particle Size | 3 | 2021 | 1644 | 0.200 |
Why?
|
Hydrodynamics | 2 | 2020 | 167 | 0.200 |
Why?
|
Computers, Molecular | 1 | 2021 | 14 | 0.190 |
Why?
|
Respiratory System Agents | 1 | 2021 | 30 | 0.190 |
Why?
|
Fibrinolysin | 1 | 2021 | 131 | 0.190 |
Why?
|
Perfusion | 2 | 2024 | 1376 | 0.190 |
Why?
|
Microbial Consortia | 1 | 2021 | 33 | 0.190 |
Why?
|
Nanocapsules | 2 | 2012 | 92 | 0.190 |
Why?
|
Erythrocytes | 2 | 2022 | 2415 | 0.180 |
Why?
|
Adhesives | 1 | 2020 | 65 | 0.180 |
Why?
|
Time-Lapse Imaging | 1 | 2021 | 193 | 0.170 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2021 | 280 | 0.170 |
Why?
|
Tissue Scaffolds | 3 | 2022 | 928 | 0.160 |
Why?
|
Apyrase | 1 | 2021 | 373 | 0.160 |
Why?
|
Synthetic Biology | 1 | 2021 | 185 | 0.160 |
Why?
|
Capillaries | 1 | 2022 | 744 | 0.160 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2543 | 0.160 |
Why?
|
Animals | 17 | 2024 | 167960 | 0.150 |
Why?
|
Drug Carriers | 2 | 2019 | 709 | 0.150 |
Why?
|
Arginine | 1 | 2021 | 934 | 0.150 |
Why?
|
Bioreactors | 1 | 2019 | 244 | 0.150 |
Why?
|
Europe | 1 | 2024 | 3441 | 0.150 |
Why?
|
Prosthesis Design | 1 | 2024 | 2129 | 0.140 |
Why?
|
Humans | 25 | 2024 | 760613 | 0.140 |
Why?
|
Fibrinogen | 1 | 2020 | 887 | 0.140 |
Why?
|
Platelet Activation | 1 | 2020 | 660 | 0.140 |
Why?
|
Motion | 1 | 2020 | 779 | 0.140 |
Why?
|
Computer Simulation | 2 | 2020 | 6218 | 0.140 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2021 | 1347 | 0.130 |
Why?
|
Microscopy | 1 | 2021 | 885 | 0.130 |
Why?
|
Polyglycolic Acid | 2 | 2017 | 405 | 0.120 |
Why?
|
Pattern Recognition, Automated | 1 | 2021 | 994 | 0.120 |
Why?
|
Embolization, Therapeutic | 1 | 2024 | 1412 | 0.120 |
Why?
|
Blood Flow Velocity | 1 | 2018 | 1377 | 0.120 |
Why?
|
Pressure | 1 | 2017 | 1156 | 0.120 |
Why?
|
Heparin | 1 | 2021 | 1652 | 0.120 |
Why?
|
Aortic Valve | 1 | 2024 | 1996 | 0.110 |
Why?
|
Biological Transport | 1 | 2018 | 2086 | 0.110 |
Why?
|
Polymers | 3 | 2021 | 1621 | 0.110 |
Why?
|
Lung | 2 | 2022 | 9994 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3734 | 0.110 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 432 | 0.110 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2108 | 0.100 |
Why?
|
Stroke | 1 | 2015 | 9952 | 0.100 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2012 | 54 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18137 | 0.100 |
Why?
|
Hemorheology | 1 | 2012 | 144 | 0.100 |
Why?
|
Mesenteric Arteries | 1 | 2012 | 178 | 0.100 |
Why?
|
Escherichia coli | 2 | 2021 | 4219 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1664 | 0.100 |
Why?
|
Blood Circulation | 1 | 2012 | 249 | 0.100 |
Why?
|
Lactic Acid | 2 | 2017 | 1134 | 0.090 |
Why?
|
Antigens, CD | 1 | 2021 | 4000 | 0.090 |
Why?
|
Blood Vessels | 1 | 2016 | 1112 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6538 | 0.080 |
Why?
|
Drug Design | 1 | 2015 | 1061 | 0.080 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2012 | 507 | 0.080 |
Why?
|
Extracellular Matrix | 2 | 2019 | 1726 | 0.080 |
Why?
|
Particulate Matter | 1 | 2020 | 2559 | 0.080 |
Why?
|
Platelet Function Tests | 2 | 2021 | 303 | 0.080 |
Why?
|
Models, Anatomic | 1 | 2012 | 682 | 0.080 |
Why?
|
Models, Biological | 2 | 2021 | 9468 | 0.080 |
Why?
|
Femoral Artery | 2 | 2022 | 831 | 0.070 |
Why?
|
Protein Binding | 1 | 2019 | 9335 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2021 | 18955 | 0.070 |
Why?
|
Mice | 7 | 2021 | 81209 | 0.070 |
Why?
|
Reference Standards | 2 | 2021 | 1004 | 0.070 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2012 | 806 | 0.060 |
Why?
|
Islets of Langerhans | 1 | 2011 | 1345 | 0.060 |
Why?
|
Neovascularization, Physiologic | 2 | 2022 | 1336 | 0.060 |
Why?
|
Endovascular Procedures | 1 | 2015 | 2134 | 0.050 |
Why?
|
Ink | 1 | 2021 | 47 | 0.050 |
Why?
|
Methacrylates | 1 | 2021 | 109 | 0.050 |
Why?
|
Rabbits | 2 | 2019 | 4773 | 0.050 |
Why?
|
Bioengineering | 1 | 2021 | 96 | 0.040 |
Why?
|
Quorum Sensing | 1 | 2021 | 137 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22020 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6216 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 4167 | 0.040 |
Why?
|
Anastomosis, Surgical | 1 | 2022 | 983 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2021 | 2558 | 0.040 |
Why?
|
Morphogenesis | 1 | 2022 | 740 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2021 | 485 | 0.040 |
Why?
|
Collagen Type I | 1 | 2021 | 616 | 0.040 |
Why?
|
Rheology | 1 | 2019 | 348 | 0.040 |
Why?
|
Suspensions | 1 | 2017 | 66 | 0.040 |
Why?
|
Excipients | 1 | 2017 | 97 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2012 | 10442 | 0.030 |
Why?
|
Microbubbles | 1 | 2017 | 128 | 0.030 |
Why?
|
Ultrasonics | 1 | 2017 | 207 | 0.030 |
Why?
|
Communication | 2 | 2021 | 3849 | 0.030 |
Why?
|
Immunotherapy | 1 | 2011 | 4642 | 0.030 |
Why?
|
Hydrogels | 1 | 2021 | 723 | 0.030 |
Why?
|
Rats | 2 | 2022 | 23709 | 0.030 |
Why?
|
Cell Line, Tumor | 3 | 2019 | 16932 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1019 | 0.030 |
Why?
|
Molecular Weight | 1 | 2017 | 2186 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1157 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1273 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2019 | 1972 | 0.030 |
Why?
|
Swine | 1 | 2022 | 5899 | 0.030 |
Why?
|
Mice, Nude | 1 | 2019 | 3607 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2021 | 5869 | 0.020 |
Why?
|
Doxorubicin | 1 | 2017 | 2208 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8158 | 0.020 |
Why?
|
Cattle | 1 | 2015 | 3847 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2019 | 2825 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15760 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2017 | 1689 | 0.020 |
Why?
|
Stem Cells | 1 | 2021 | 3524 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4902 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 22075 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3484 | 0.020 |
Why?
|
Male | 4 | 2021 | 359718 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4046 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8552 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 64981 | 0.000 |
Why?
|
Female | 2 | 2019 | 391246 | 0.000 |
Why?
|
Concepts
(153)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_